Low public interest, short shelf life to blame for wasted COVID jabs – DOH
MANILA, Philippines — The wasted COVID-19 vaccines can be attributed to a lowered public interest and the short shelf life, said Department of Health officer-in-charge (DOH-OIC) Maria Rosario Vergeire on Tuesday.
In a media forum, Vergeire was asked about the 44 million COVID-19 vaccines that recently have gone to waste.
“Nandiyan na ang pagbaba ng interes ng ating mga kababayan sa pagbabakuna. Kung mapapansin niyo, in spite of the, all efforts, best efforts ng local governments, mobilized our partners from the private sector, partners from our medical societies, at lahat lahat na—from government agencies. Pero talagang mababa na ngayon ang uptake ng pagbabakuna,” said Vergeire.
(The lowered interest of the public in vaccinations is there. If you notice, despite the best efforts of local governments, mobilizing our partners from the private sector, partners from our medical societies, government agencies and all. But the uptake of the vaccine is low).
Vergeire further explained that vaccination rates peaked in December 2021, but started to decline by January 2022.
According to the OIC, COVID-19 jabs also had shorter shelf-lives compared to vaccines of other illnesses.
“They are just in their [Emergency Use Authorization], so the manufacturers, they produce the vaccines at a much shorter shelf life,” stated Vergeire.
Other countries were also experiencing the same wastage of COVID-19 vaccines, said Vergeire.
The World Health Organization stated in July 2021 that COVID-19 vaccines have a short shelf life, prompting them to set guidelines on how to minimize wastage, including monitoring data to utilize the vaccines and creating strategies for distribution.
RELATED STORIES
DOH: Wasted COVID-19 jabs now at 44 million doses
More than 170,000 COVID vaccines wasted in Central Visayas
202 COVID vaccine doses wasted in Region 7 – VVOC
The post Low public interest, short shelf life to blame for wasted COVID jabs – DOH appeared first on Cebu Daily News.
No comments: